Michele Cioffi

Cornell University US

0000-0003-4180-5369

Publications

4,410

Citations

H-Index

i10-Index

14.5

2yr Mean Cite

Cite/Paper

Data combined from OpenAlex + Semantic Scholar. OA = OpenAlex S2 = Semantic Scholar

Verify on Google Scholar

Publication & Citation Trends

Publications

0 total

A first-in-human study of MT-303, an innovative in vivo mRNA chimeric antigen receptor (CAR) therapy targeting GPC3, in adults with hepatocellular carcinoma.

Timothy Guy Humphries, Stuart K. Roberts, Hao‐Wen Sim, Yoon Jun Kim, H. Chon - Journal of Clinical Oncology, 2025

Cited by 2 Semantic Scholar

First-in-human mRNA CAR therapy: Correlative biomarker analysis from the MT-302 phase 1 study targeting TROP2 in patients with advanced epithelial tumors.

C. Lemech, R. Cosman, Timothy Guy Humphries, G. Kichenadasse, G. Richardson - Journal of Clinical Oncology, 2025

Cited by 4 Semantic Scholar

1342 First-in-human dose escalation study to investigate the safety, pharmacokinetics, pharmacodynamics and initial efficacy of mRNA-LNP MT-302 in vivo CAR therapy in solid tumors

C. Lemech, T.G. Humphries, G. Kichenadasse, G. Richardson, Adnan Nagrial - Late-Breaking Abstracts, 2025

Cited by 1 Semantic Scholar

676TiP MYE Symphony: A first-in-human study to investigate the safety, pharmacokinetics, pharmacodynamics and preliminary efficacy of the in vivo mRNA CAR therapy, MT-302, targeting TROP2 in adults with advanced epithelial tumors

C. Lemech, G. Kichenadasse, C. Teng, A. Nagrial, G. Richardson - Annals of Oncology, 2024

Cited by 2 Semantic Scholar

Research Topics

Cancer Cells and Metastasis (18) Pancreatic and Hepatic Oncology Research (17) Cancer Research and Treatments (11) Extracellular vesicles in disease (10) MicroRNA in disease regulation (7)

Affiliations

Cornell University

US 2025 - 2020

Spanish National Cancer Research Centre

ES 2023 - 2010

Center for Children

US 2022 - 2022

Clinical Research Organization

BD 2012 - 2012

New York Proton Center

US 2022 - 2022

External Profiles

OpenAlex Profile Semantic Scholar Profile ORCID Profile Google Scholar

Share Profile

Back to Researchers

Michele Cioffi

Publication & Citation Trends

Publications

A first-in-human study of MT-303, an innovative in vivo mRNA chimeric antigen receptor (CAR) therapy targeting GPC3, in adults with hepatocellular carcinoma.

First-in-human mRNA CAR therapy: Correlative biomarker analysis from the MT-302 phase 1 study targeting TROP2 in patients with advanced epithelial tumors.

1342 First-in-human dose escalation study to investigate the safety, pharmacokinetics, pharmacodynamics and initial efficacy of mRNA-LNP MT-302 in vivo CAR therapy in solid tumors

676TiP MYE Symphony: A first-in-human study to investigate the safety, pharmacokinetics, pharmacodynamics and preliminary efficacy of the in vivo mRNA CAR therapy, MT-302, targeting TROP2 in adults with advanced epithelial tumors

Research Topics

Affiliations

External Profiles

Share Profile

Journal Details

Join JournalsHub

Welcome Back